HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA
Clinical trials for HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA trials appear
Sign up with your email to follow new studies for HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibiotic cocktail takes on superbugs in phase 3 trial
Disease control CompletedThis study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against the best available treatments for adults with serious infections like urinary tract infections, pneumonia, and abdominal infections caused by carbapenem-resistant bacteria. Th…
Matched conditions: HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New antibiotic cocktail aims to beat tough hospital pneumonia
Disease control CompletedThis study tested a new antibiotic combination (IMI-XNW4107) against an existing one (IMI/REL) in 450 adults with serious pneumonia caught in the hospital or from a ventilator. The main goal was to see if the new drug was at least as good at preventing death within 14 days. Both …
Matched conditions: HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA
Phase: PHASE3 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC